Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL CELL COUNTING DEVICES MARKET SIZE IS EXPECTED TO REACH USD 18.64 BILLION BY 2029 FROM USD 12.39 BILLION IN 2023, GROWING AT A CAGR OF 7.04% DURING THE FORECAST PERIOD.
The Cell Counting Devices Market Size, Share, & Trends Analysis Report By
- Product: Consumables and Instruments
- Applications: Research, Development, & Bioprocessing, Clinical Diagnostics, and Other Applications
- End-Users: Pharma & Biotech Companies, Diagnostics Laboratories, Research Institutes & Labs, CDMOs & CROs, and Other End-users
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
CELL COUNTING DEVICES MARKET REPORT SCOPE
REPORT ATTRIBUTE | DETAILS |
---|---|
Market Size (2029) | USD 18.64 Billion |
Market Size (2023) | USD 12.39 Billion |
CAGR (2023-2029) | 7.04% |
HISTORIC YEAR | 2020-2022 |
BASE YEAR | 2023 |
FORECAST YEAR | 2024-2029 |
SEGMENTS BY | Product, Applications, End-Users, and Geography |
GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
KEY PLAYERS | Abbott, Bio-Rad Laboratories, Boule, Danaher, Diatron, HORIBA, Merck KGaA, PerkinElmer, Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific |
INDUSTRY OVERVIEW
The global cell counting devices market was valued at USD 12.39 billion in 2023 and is expected to reach USD 18.64 billion by 2029, growing at a CAGR of 7.04% during the forecast period. The market has witnessed significant development in the past few years. Cell counting devices are essential for clinical and pharma & biotech industries, from research & development to final product development and manufacturing processes. The continued development of cell counters, from traditional and manual to automated, the integration of advanced tools and technologies, and the growth of the cell counting devices market have shown promising development in the coming years. Also, automated cell counting devices are changing the market landscape by offering several advantages over traditional ones. As the pharma, biotech, and healthcare industries are growing rapidly, their investment and understanding of automated cell counters are rising rapidly, accelerating market development.
MARKET TRENDS & DRIVERS
Technology Advancements in Cell Counting Devices
Cell counting is essential for biologists who work with/on cells for cell culture. Manual cell counting has been the most popular method in the past few decades and is commonly used across life sciences sectors. However, the development from manual to automated cell counting devices, integration and adoption of innovative technologies such as flow cytometry and image-based cell counting systems, and integration of new modules and tools are revolutionizing the cell counting devices market landscape and are expected to deliver significant growth opportunities. The most recent advancement, the introduction of image-based cell counters, delivers the benefits of continuous development of image analysis algorithms and machine learning for more consistent and faster counting. Certainly, computer-based image analysis helps detect features easily missed by the human eye. All these developments emerge rapidly as the industry develops with automated cell counting devices. These advanced systems lighten traditional methods' changeability, providing faster throughputs and superior accuracy.
Increasing Application Areas for Cell Counting Devices
Cell counting is an essential operation in several fields and industries. It is fundamental for research biologists who work with cells. From cell culture- seeding cells at adequate densities, monitoring cell health and proliferation, and facilitating proper passaging to vital for in-vitro experiments. Cell counting has become essential in several industries, from disease diagnosis to drug development and production, and has gained significant attention in the past few years. In pharmaceutical, academic, and industrial sectors, major factors, such as stem cell research, regenerative medicines, and personalized medicines, are trending factors closely associated with cell culture and analysis, which deliver lucrative opportunities for cell counting. Most biological applications work on cells, such as blood work, cell culture, and microbiology, expand the growth of the cell counting devices market. Also, the growing research across stem cell research and regenerative medicines offers lucrative opportunities for cell counting devices. In stem cell research and regenerative medicine development, the requirement of consistent cell counts to achieve successful work in research activities and cell counting devices play an essential role. In recent years, the rising attention in stem cell research across industry and academic sectors is due to cells' potential to alleviate and cure many health conditions.
Growing Burden of Chronic Disorders
The cell counting devices market is gaining popularity in the healthcare industry to diagnose, treat, and monitor several health conditions. Hospitals and clinics widely use cell counting devices to measure and determine patient health. In clinical diagnosis, hematology analysis of body fluids delivers valuable information and indicates clinical health conditions. The full blood count is regularly/routinely performed in health settings to measure diagnosis in health settings, which involves cell counting in blood samples. Moreover, the growing burden of chronic diseases boosts the demand for cell-counting devices. Cell counting is the most important consideration for cancer, autoimmune diseases, and CVD diseases, as well as for diagnosis, monitoring, and effective treatment delivery. Conversely, automated cell counting devices are recognized as vital to eliminating the extra workforce cost burden and monitoring development and manufacturing processes in drug discovery for these health conditions.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT
The global cell counting devices market by product is segmented into consumables and instruments. The consumables segment holds the dominating segmental market share in 2023. The consumables in the cell counting procedures include assay, reagent, accessories, software analysis algorithms, assay kits, microplates, and accessories such as beads, slides, plates, and others. A broad range of consumables are used with cell counters that help optimize instrument setup, sampling preparation, and quality control. The application rate of cell-counting consumables is comparatively higher than that of instruments. Consumables are used and discarded, which demand continued investment that drives significant market growth.
The instrument segment includes spectrophotometers, flow cytometers, hematology analyzers, manual cell counters/hemocytometers, automated cell counters, and Coulter counters. Cell counting devices, including manual and automated ones, are considered instruments in the study report. The growth of the segment heavily relies on technological advancements in cell counters. The available automated cell counters offer more precision and reduce the work burden and human errors. The popularity of automated cell counters is accelerating segmental growth. Furthermore, automated cell counters offer higher throughput and become an alternative to other cell counter instruments; apart from that, the rising preference for flow cytometers, spectrophotometers, and Coulter counters positively influences segmental growth. The industry has many cell-counting devices, and they all work differently. The rising application areas for cell counters, from healthcare to breweries and dairy industries, have boosted the market share significantly.
INSIGHTS BY APPLICATION
The global cell counting devices market by applications is segmented into research, development, & bioprocessing, clinical diagnostics, and other applications. The research, development, & bioprocessing segment holds the most significant share of the global market in 2023. The rapidly growing research, development, and bioprocessing activities across the life sciences are accelerating segmental growth. Furthermore, the growing application of cell counters in the medical field across disease diagnosis and associated activities are some of the leading factors propelling clinical diagnostics segmental growth.
INSIGHTS BY END-USERS
The global cell counting devices market by end-users is segmented into pharma & biotech companies, diagnostics laboratories, research institutes & labs, CDMOs & CROs, and other end-users. By end-users, the pharma & biotech companies accounted for most of the segmental market share in 2023. Pharma and biotech companies that are highly investing in the R&D of novel drugs and therapies widely perform research studies. Cell counting devices play a major role in developing cell and gene-based therapies, regenerative medicines, advanced biologics, vaccines, and others that require the study of various cells, where cell counters are most commonly used by pharma & biotech companies.
GEOGRAPHICAL ANALYSIS
North America dominated the global cell counting devices market share, accounting for a global share of over 36% in 2023. The region is dominating the global market with the rise in the aging population, prevalence of chronic diseases, increasing healthcare expenditure, need for advanced healthcare, presence of well-established players, and a major shift towards automation in cell counting devices. Most importantly, the presence of several manufacturers producing automated cell counting equipment with a wide range of products according to the margin of affordability contributes to the region’s highest share in the global market. Furthermore, in North America, the U.S. is a major market landscape that achieves the highest revenue growth for cell counting devices compared to other countries worldwide.
Europe holds a significant position in the global cell counting devices market in 2023. In Europe, a significant patient population with chronic diseases raises research and development activities across life sciences industries, delivering lucrative market growth opportunities. Furthermore, the growing research across cell and gene therapies, stem cells, and regenerative medicines drives the region's demand for automated cell counters. Also, APAC will likely be the fastest-growing region in the global cell counting devices market during the forecast period. This is mostly due to the growing aging population in need of diagnosis and treatment, the rise in prevalence of chronic diseases, demand for high-quality healthcare, growing healthcare infrastructure, and most importantly, the increasing number of healthcare centers such as hospitals, clinics, diagnostics centers, laboratories, and others.
VENDOR LANDSCAPE
The global cell counting devices market is exceptionally active, with several global, regional, and local players offering various cell counters. Also, the hematology analyzers used for cell analysis and counting significantly influence vendor competition. Several leading hematology analyzer companies compete with cell counting device manufacturing companies. The market is increasingly competitive, and vendors are highly focused on making partnerships and collaborations to maintain a competitive edge over other players. For instance, in 2022, Merck KGaA made a research collaboration and commercial license agreement with Mersana Therapeutics to discover novel antibody-drug conjugates.
Key players account for the major share of the global cell counting devices market. These key vendors include Abbott, Bio-Rad Laboratories, Boule, Danaher, Diatron, Merck KGaA, Horiba, Thermo Fisher Scientific, PerkinElmer, Siemens Healthineers, and Sysmex Corporation. Abbott offers high-quality hematology analyzers in the cell counting devices industry that meet a broad range of cell counting requirements. Abbott offers various medical diagnostics instruments, tests, automation, informatics, and solutions for multiple end-users. In 2018, Abbott strengthened its position in diagnostics by introducing Alinity, a separate platform for laboratory operations, tests, and services. Abbott has a complete portfolio of hematology solutions for cell count procedures, including automated analyzers, slide-maker strainers, reagents, calibrators, and controls for laboratories with diverse testing volumes. CELL-DYN Emerald 22 is the latest hematology analyzer introduced by Abbott.
Frequently Asked Questions
What is the growth rate of the global cell counting devices market?
How big is the cell counting devices market?
What are the significant trends in the cell counting devices industry?
Which region dominates the global cell counting devices market share?
Who are the key players in the global cell counting devices market?
The global cell counting devices market size is expected to grow at a CAGR of approximately 7.04% from 2023 to 2029.
The following factors are likely to contribute to the growth of the global cell counting devices market during the forecast period:
- Growing Burden of the Chronic Disorders
- Rapid Shift from Manual to the Automated Cell Counting Devices
- Continuously Increasing Research and Drug Discovery Activities
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global cell counting devices market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- AbbottBusiness
- Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Bio-Rad Laboratories
- Boule
- Danaher
- Diatron
- HORIBA
- Merck KGaA
- PerkinElmer
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
Other Prominent Vendors
- Advanced Instruments
- Business Overview
- Product Offerings
- Agilent Technologies
- Axion BioSystems
- Aligned Genetics (Logos Biosystems)
- Alphatec Scientific
- Agappe Diagnostics
- Analyticon Biotechnologies
- Balio Diagnostics
- B&E BIO-TECHNOLOGY
- BioSystems Diagnostics
- Bioway Biological Technology
- BIOSYSY Scientific Devices GmbH
- Benchmark Scientific
- BD
- Bruker Spatial Biology (NanoString Technologies, Inc.)
- Bentley Instruments
- ChemoMetec
- Corning Incorporated
- Curiosis Inc
- Cytek Biosciences
- Cole-Parmer Instrument Company
- Cellular Technology Limited (Immunospot)
- CLINDIAG SYSTEMS
- CONTECH MEDICAL SYSTEMS
- Convergent Technologies
- CPC Diagnostics
- DIAGON
- Dirui
- Drucker Diagnostics
- DeNovix
- EDAN Instruments
- F. Hoffmann-La Roche
- Genrui Biotech
- High Technology
- Hospitex International Ltd
- LINEAR CHEMICALS
- Maccura Biotechnology
- Meril Life Sciences
- Medsource Ozone Biomedicals
- NIHON KOHDEN CORPORATION
- Norma Instruments
- NanoEntek
- Paul Marienfeld GmbH & Co. KG
- RWD Life Sciences Co., LTD.
- Revvity
- Sartorius AG
- Shenzhen Mindray Bio-Medical Electronics
- Shenzhen Landwind Industry
- Prestige Diagnostics
- SFRI
- Shenzhen Dymind Biotechnology
- Shenzhen Prokan Electronics
- SPINREACT
- Trivitron Healthcare
- Tecan Trading Ag
- Tip Biosystems
Segmentation by Product
- Consumables
- Instruments
Segmentation by Applications
- Research, Development, & Bioprocessing
- Clinical Diagnostics
- Other Applications
Segmentation by End-Users
- Pharma & Biotech Companies
- Diagnostics Laboratories
- Research Institutes & Labs
- CDMOs & CROs
- Other End-users
Segmentation by Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Russia
- Poland
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
LIST OF EXHIBITS
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 CELL COUNTING DEVICES: MARKET DYNAMICS
EXHIBIT 3 IMPACT OF TECHNOLOGICAL ADVANCES IN CELL COUNTING DEVICES
EXHIBIT 4 MOST RECENT TECHNOLOGICAL ADVANCES IN CELL COUNTING DEVICES:
EXHIBIT 5 OUTCOMES OF LEVERAGING VISUAL AI FOR CELL COUNTING
EXHIBIT 6 IMPACT OF INCREASING APPLICATION AREAS FOR CELL COUNTING DEVICES
EXHIBIT 7 IMPACT OF RISING FOCUS ON FLOW CYTOMETRY IN CELL COUNTING
EXHIBIT 8 FACTORS ENABLING FLOW CYTOMETRY IN CELL COUNTING
EXHIBIT 9 IMPACT OF GROWING BURDEN OF CHRONIC DISORDERS
EXHIBIT 10 GLOBAL CANCER CASES BY TYPE 2021
EXHIBIT 11 IMPACT OF RAPID SHIFT FROM MANUAL TO AUTOMATED CELL COUNTING DEVICES
EXHIBIT 12 IMPACT OF EXPANSION OF APPLICATION AREAS IN RESEARCH AND DRUG DISCOVERY ACTIVITIES
EXHIBIT 13 IMPACT OF CHALLENGES ASSOCIATED WITH CELL COUNTING
EXHIBIT 14 IMPACT OF COST OF CELL COUNTING DEVICES
EXHIBIT 15 IMPACT OF LACK OF EXPERTISE, AUTOMATION, & HUMAN ERRORS
EXHIBIT 16 GLOBAL CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH BY GEOGRAPHY
EXHIBIT 17 CELL COUNTING DEVICES MARKET SEGMENTATION
EXHIBIT 18 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT: SHARE ANALYSIS 2023 & 2029 (%)
EXHIBIT 19 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION: SHARE ANALYSIS 2023 & 2029 (%)
EXHIBIT 20 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS: SHARE ANALYSIS 2023 & 2029 (%)
EXHIBIT 21 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY: SHARE ANALYSIS 2023 & 2029 (%)
EXHIBIT 22 GLOBAL CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 23 FIVE FORCES ANALYSIS 2023
EXHIBIT 24 INCREMENTAL GROWTH BY PRODUCT 2023 & 2029
EXHIBIT 25 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT 2023-2029
EXHIBIT 26 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 27 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH (%)
EXHIBIT 28 GLOBAL CELL COUNTING CONSUMABLES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL CELL COUNTING CONSUMABLES MARKET 2023–2029 ($ BILLION)
EXHIBIT 30 GLOBAL CELL COUNTING INSTRUMENTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL CELL COUNTING INSTRUMENTS MARKET 2023–2029 ($ BILLION)
EXHIBIT 32 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 33 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION 2023-2029
EXHIBIT 34 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 35 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 36 CELL & GENE THERAPIES STATISTICS
EXHIBIT 37 GLOBAL RESEARCH, DEVELOPMENT & BIOPROCESSING CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL RESEARCH, DEVELOPMENT, AND BIOPROCESSING CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 39 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 41 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY END-USERS 2023 & 2029
EXHIBIT 44 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS 2023-2029
EXHIBIT 45 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 46 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS: ABSOLUTE GROWTH (%)
EXHIBIT 47 APPLICATION AREAS FOR CELL COUNTERS IN PHARMA & BIOTECH COMPANIES
EXHIBIT 48 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 50 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 52 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 53 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 54 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 56 GLOBAL OTHER END-USERS: CELL COUNTING DEVICES MARKET INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL OTHER END-USERS CELL COUNTING DEVICES MARKET 2023–2029 ($ BILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 59 THE GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023-2029
EXHIBIT 60 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 61 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 62 CELL COUNTING DEVICES MARKET IN NORTH AMERICA: KEY COUNTRIES REVENUE ($ BILLION) 2023
EXHIBIT 63 CELL COUNTING DEVICES MARKET IN NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 CELL COUNTING DEVICES MARKET IN NORTH AMERICA 2023–2029 ($ BILLION)
EXHIBIT 65 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 66 CHRONIC DISEASES BURDEN IN THE US 2023
EXHIBIT 67 CELL COUNTING DEVICES MARKET IN US 2023–2029 ($ BILLION)
EXHIBIT 68 CHRONIC DISEASES BURDEN IN CANADA 2020
EXHIBIT 69 CELL COUNTING DEVICES MARKET IN CANADA 2023–2029 ($ BILLION)
EXHIBIT 70 CELL COUNTING DEVICES MARKET IN EUROPE: KEY COUNTRIES REVENUE ($ BILLION) 2023
EXHIBIT 71 CELL COUNTING DEVICES MARKET IN EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 72 CELL COUNTING DEVICES MARKET IN EUROPE 2023–2029 ($ BILLION)
EXHIBIT 73 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 74 CHRONIC DISEASES BURDEN IN GERMANY 2022
EXHIBIT 75 CELL COUNTING DEVICES MARKET IN GERMANY 2023–2029 ($ BILLION)
EXHIBIT 76 CELL COUNTING DEVICES MARKET IN FRANCE 2023–2029 ($ BILLION)
EXHIBIT 77 ESTIMATED AND PREDICTED CANCER BURDEN IN THE UK (CASES IN MILLION) 2020-2040
EXHIBIT 78 CELL COUNTING DEVICES MARKET IN UK 2023–2029 ($ BILLION)
EXHIBIT 79 CELL COUNTING DEVICES MARKET IN ITALY 2023–2029 ($ BILLION)
EXHIBIT 80 CELL COUNTING DEVICES MARKET IN SPAIN 2023–2029 ($ BILLION)
EXHIBIT 81 CELL COUNTING DEVICES MARKET IN RUSSIA 2023–2029 ($ BILLION)
EXHIBIT 82 CELL COUNTING DEVICES MARKET IN POLAND 2023–2029 ($ BILLION)
EXHIBIT 83 CELL COUNTING DEVICES MARKET IN APAC: KEY COUNTRIES REVENUE ($ BILLION) 2023
EXHIBIT 84 CELL COUNTING DEVICES MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 85 CELL COUNTING DEVICES MARKET IN APAC 2023–2029 ($ BILLION)
EXHIBIT 86 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 87 CELL COUNTING DEVICES MARKET IN CHINA 2023–2029 ($ BILLION)
EXHIBIT 88 CELL COUNTING DEVICES MARKET IN JAPAN 2023–2029 ($ BILLION)
EXHIBIT 89 CANCER PREVALENCE IN INDIA: ESTIMATED & PREDICTED PREVALENCE (MILLION) 2018–2025
EXHIBIT 90 CELL COUNTING DEVICES MARKET IN INDIA 2023–2029 ($ BILLION)
EXHIBIT 91 CELL COUNTING DEVICES MARKET IN SOUTH KOREA 2023–2029 ($ BILLION)
EXHIBIT 92 CELL COUNTING DEVICES MARKET IN AUSTRALIA 2023–2029 ($ BILLION)
EXHIBIT 93 CELL COUNTING DEVICES MARKET IN INDONESIA 2023–2029 ($ BILLION)
EXHIBIT 94 CELL COUNTING DEVICES MARKET IN LATIN AMERICA: KEY COUNTRIES REVENUE ($ BILLION) 2023
EXHIBIT 95 CELL COUNTING DEVICES MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 96 CELL COUNTING DEVICES MARKET IN LATIN AMERICA 2023–2029 ($ BILLION)
EXHIBIT 97 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 98 CELL COUNTING DEVICES MARKET IN BRAZIL 2023–2029 ($ BILLION)
EXHIBIT 99 CELL COUNTING DEVICES MARKET IN MEXICO 2023–2029 ($ BILLION)
EXHIBIT 100 CELL COUNTING DEVICES MARKET IN ARGENTINA 2023–2029 ($ BILLION)
EXHIBIT 101 CELL COUNTING DEVICES MARKET IN MEA: KEY COUNTRIES REVENUE ($ BILLION) 2023
EXHIBIT 102 CELL COUNTING DEVICES MARKET IN MEA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 103 CELL COUNTING DEVICES MARKET IN MEA 2023–2029 ($ BILLION)
EXHIBIT 104 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 105 CELL COUNTING DEVICES MARKET IN TURKEY 2023–2029 ($ BILLION)
EXHIBIT 106 CELL COUNTING DEVICES MARKET IN SAUDI ARABIA 2023–2029 ($ BILLION)
EXHIBIT 107 CELL COUNTING DEVICES MARKET IN SOUTH AFRICA 2023–2029 ($ BILLION)
EXHIBIT 108 CELL COUNTING DEVICES MARKET IN UAE 2023–2029 ($ BILLION)
EXHIBIT 109 MARKET DOMINANCE ANALYSIS OF VENDORS OFFERING CELL COUNTING DEVICES
EXHIBIT 110 CAPABILITIES & EXPERT ASSESSMENT OF VENDORS OFFERING CELL COUNTING DEVICES
EXHIBIT 111 KEY CAVEATS
LIST OF TABLES
TABLE 1 SOME EXAMPLES OF CELL COUNTING REAGENTS
TABLE 2 SOME EXAMPLES OF CELL COUNTING BEADS
TABLE 3 SOFTWARE FOR CELL COUNTERS
TABLE 4 GLOBAL CELL COUNTING CONSUMABLES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 5 GLOBAL CELL COUNTING CONSUMABLES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 6 GLOBAL CELL COUNTING INSTRUMENTS MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 7 GLOBAL CELL COUNTING INSTRUMENTS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 8 GLOBAL RESEARCH, DEVELOPMENT, AND BIOPROCESSING CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 9 GLOBAL RESEARCH, DEVELOPMENT, AND BIOPROCESSING CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 10 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 11 GLOBAL CLINICAL DIAGNOSTICS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 12 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 13 GLOBAL OTHER APPLICATIONS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 14 CELL COUNTING DEVICES MAJOR APPLICATIONS IN PHARMA & BIOTECH COMPANIES
TABLE 15 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 16 GLOBAL PHARMA & BIOTECH COMPANIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 17 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 18 GLOBAL DIAGNOSTICS LABORATORIES CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 19 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 20 GLOBAL RESEARCH INSTITUTES & LABS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 21 SOME MAJOR CELL & GENE THERAPY CROS & CDMOS (2022 & 2023)
TABLE 22 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 23 GLOBAL CDMOS & CROS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 24 GLOBAL OTHER END-USERS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 25 GLOBAL OTHER END-USERS CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 26 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2023−2029 ($ BILLION)
TABLE 27 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2023−2029 (%)
TABLE 28 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY APPLICATION 2023−2029 ($ BILLION)
TABLE 29 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY APPLICATION 2023−2029 (%)
TABLE 30 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY END-USERS 2023−2029 ($ BILLION)
TABLE 31 CELL COUNTING DEVICES MARKET IN NORTH AMERICA BY END-USERS 2023−2029 (%)
TABLE 32 CELL COUNTING DEVICES MARKET IN EUROPE BY PRODUCT 2023−2029 ($ BILLION)
TABLE 33 CELL COUNTING DEVICES MARKET IN EUROPE BY PRODUCT 2023−2029 (%)
TABLE 34 CELL COUNTING DEVICES MARKET IN EUROPE BY APPLICATION 2023−2029 ($ BILLION)
TABLE 35 CELL COUNTING DEVICES MARKET IN EUROPE BY APPLICATION 2023−2029 (%)
TABLE 36 CELL COUNTING DEVICES MARKET IN EUROPE BY END-USERS 2023−2029 ($ BILLION)
TABLE 37 CELL COUNTING DEVICES MARKET IN EUROPE BY END-USERS 2023−2029 (%)
TABLE 38 CANCER CASES DIAGNOSED IN THE UK
TABLE 39 CELL COUNTING DEVICES MARKET IN APAC BY PRODUCT 2023−2029 ($ BILLION)
TABLE 40 CELL COUNTING DEVICES MARKET IN APAC BY PRODUCT 2023−2029 (%)
TABLE 41 CELL COUNTING DEVICES MARKET IN APAC BY APPLICATION 2023−2029 ($ BILLION)
TABLE 42 CELL COUNTING DEVICES MARKET IN APAC BY APPLICATION 2023−2029 (%)
TABLE 43 CELL COUNTING DEVICES MARKET IN APAC BY END-USERS 2023−2029 ($ BILLION)
TABLE 44 CELL COUNTING DEVICES MARKET IN APAC BY END-USERS 2023−2029 (%)
TABLE 45 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY PRODUCT 2023−2029 ($ BILLION)
TABLE 46 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY PRODUCT 2023−2029 (%)
TABLE 47 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY APPLICATION 2023−2029 ($ BILLION)
TABLE 48 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY APPLICATION 2023−2029 (%)
TABLE 49 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY END-USERS 2023−2029 ($ BILLION)
TABLE 50 CELL COUNTING DEVICES MARKET IN LATIN AMERICA BY END-USERS 2023−2029 (%)
TABLE 51 CELL COUNTING DEVICES MARKET IN MEA BY PRODUCT 2023−2029 ($ BILLION)
TABLE 52 CELL COUNTING DEVICES MARKET IN MEA BY PRODUCT 2023−2029 (%)
TABLE 53 CELL COUNTING DEVICES MARKET IN MEA BY APPLICATION 2023−2029 ($ BILLION)
TABLE 54 CELL COUNTING DEVICES MARKET IN MEA BY APPLICATION 2023−2029 (%)
TABLE 55 CELL COUNTING DEVICES MARKET IN MEA BY END-USERS 2023−2029 ($ BILLION)
TABLE 56 CELL COUNTING DEVICES MARKET IN MEA BY END-USERS 2023−2029 (%)
TABLE 57 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 58 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 59 BOULE: MAJOR PRODUCT OFFERINGS
TABLE 60 DANAHER: MAJOR PRODUCT OFFERINGS
TABLE 61 DIATRON: MAJOR PRODUCT OFFERINGS
TABLE 62 HORIBA: MAJOR PRODUCT OFFERINGS
TABLE 63 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 64 PERKINELMER: MAJOR PRODUCT OFFERINGS
TABLE 65 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 66 SYSMEX CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 67 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 68 ADVANCED INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 69 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 70 AXION BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 71 ALIGNED GENETICS: MAJOR PRODUCT OFFERINGS
TABLE 72 ALPHATEC SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 73 AGAPPE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 74 ANALYTICON BIOTECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 75 BALIO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 76 B&E BIO-TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 77 BIOSYSTEMS DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 78 BIOWAY BIOLOGICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 79 BIOSYSY SCIENTIFIC DEVICES GMBH: MAJOR PRODUCT OFFERINGS
TABLE 80 BENCHMARK SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 81 BD: MAJOR PRODUCT OFFERINGS
TABLE 82 BRUKER SPATIAL BIOLOGY (NANOSTRING TECHNOLOGIES, INC.): MAJOR PRODUCT OFFERINGS
TABLE 83 BENTLEY INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 84 CHEMOMETEC: MAJOR PRODUCT OFFERINGS
TABLE 85 CORNING INCORPORATED: MAJOR PRODUCT OFFERINGS
TABLE 86 CURIOSIS INC: MAJOR PRODUCT OFFERINGS
TABLE 87 CYTEK BIOSCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 88 COLE-PARMER INSTRUMENT COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 89 CELLULAR TECHNOLOGY LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 90 CLINDIAG SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 91 CONTECH MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 92 CONVERGENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 93 CPC DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 94 DIAGON: MAJOR PRODUCT OFFERINGS
TABLE 95 DIRUI: MAJOR PRODUCT OFFERINGS
TABLE 96 DRUCKER DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 97 DENOVIX: MAJOR PRODUCT OFFERINGS
TABLE 98 EDAN INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 99 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 100 GENRUI BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 101 HIGH TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 102 HOSPITEX INTERNATIONAL LTD: MAJOR PRODUCT OFFERINGS
TABLE 103 LINEAR CHEMICALS: MAJOR PRODUCT OFFERINGS
TABLE 104 MACCURA BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 105 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 106 MEDSOURCE OZONE BIOMEDICALS: MAJOR PRODUCT OFFERINGS
TABLE 107 NIHON KOHDEN CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 108 NORMA INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 109 NANOENTEK: MAJOR PRODUCT OFFERINGS
TABLE 110 PAUL MARIENFELD GMBH & CO. KG: MAJOR PRODUCT OFFERINGS
TABLE 111 RWD LIFE SCIENCES CO. LTD: MAJOR PRODUCT OFFERINGS
TABLE 112 REVVITY: MAJOR PRODUCT OFFERINGS
TABLE 113 SARTORIUS AG: MAJOR PRODUCT OFFERINGS
TABLE 114 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: MAJOR PRODUCT OFFERINGS
TABLE 115 SHENZHEN LANDWIND INDUSTRY: MAJOR PRODUCT OFFERINGS
TABLE 116 PRESTIGE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 117 SFRI: MAJOR PRODUCT OFFERINGS
TABLE 118 SHENZHEN DYMIND BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 119 SHENZHEN PROKAN ELECTRONICS: MAJOR PRODUCT OFFERINGS
TABLE 120 SPINREACT: MAJOR PRODUCT OFFERINGS
TABLE 121 TRIVITRON HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 122 TECAN TRADING AG: MAJOR PRODUCT OFFERINGS
TABLE 123 TIP BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 124 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 ($ BILLION)
TABLE 125 GLOBAL CELL COUNTING DEVICES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 126 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT 2023−2029 ($ BILLION)
TABLE 127 GLOBAL CELL COUNTING DEVICES MARKET BY PRODUCT 2023−2029 (%)
TABLE 128 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION 2023−2029 ($ BILLION)
TABLE 129 GLOBAL CELL COUNTING DEVICES MARKET BY APPLICATION 2023−2029 (%)
TABLE 130 GLOBAL CELL COUNTING DEVICES MARKET BY END-USERS 2023−2029 ($ BILLION)
TABLE 131 GLOBAL CELL COUNTING DEVICES MARKET BY END-USER 2023−2029 (%)
TABLE 132 CURRENCY CONVERSION 2016−2023
1 SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. MARKET SEGMENTATION
1.2.1. MARKET BY PRODUCT
1.2.2. MARKET BY APPLICATIONS
1.2.3. MARKET BY END-USERS
1.2.4. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. HISTORIC PERIOD, BASE YEAR, & FORECAST YEARS
2 PREMIUM INSIGHTS
2.1 OPPORTUNITY POCKETS
2.2 OVERVIEW
3 MARKET AT A GLANCE
4 INTRODUCTION
4.1. OVERVIEW
5 MARKET OPPORTUNITIES & TRENDS
5.1. TECHNOLOGICAL ADVANCES IN CELL COUNTING DEVICES
5.2. INCREASING APPLICATION AREAS FOR CELL COUNTING DEVICES
5.3. RISING FOCUS ON FLOW CYTOMETRY IN CELL COUNTING
6 MARKET GROWTH ENABLERS
6.1 GROWING BURDEN OF CHRONIC DISORDERS
6.2 RAPID SHIFT FROM MANUAL TO AUTOMATED CELL COUNTING DEVICES
6.3 EXPANSION OF APPLICATION AREAS IN RESEARCH AND DRUG DISCOVERY ACTIVITIES
7 MARKET RESTRAINTS
7.1 CHALLENGES ASSOCIATED WITH CELL COUNTING
7.2 COST OF CELL COUNTING DEVICES
7.3 LACK OF EXPERTISE, AUTOMATION, & HUMAN ERRORS
8 MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.1.1. BY PRODUCT: SEGMENT INSIGHTS
8.1.2. BY APPLICATION: SEGMENT INSIGHTS
8.1.3. BY END-USERS: SEGMENT INSIGHTS
8.1.4. BY GEOGRAPHY: SEGMENT INSIGHTS
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9 PRODUCT
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. CONSUMABLES
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. MARKET BY GEOGRAPHY
9.4. INSTRUMENTS
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. MARKET BY GEOGRAPHY
10 APPLICATION
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. RESEARCH, DEVELOPMENT, & BIOPROCESSING
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. MARKET BY GEOGRAPHY
10.4. CLINICAL DIAGNOSTICS
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MARKET BY GEOGRAPHY
10.5. OTHER APPLICATIONS
10.5.1. MARKET OVERVIEW
10.5.2. MARKET SIZE & FORECAST
10.5.3. MARKET BY GEOGRAPHY
11 END-USERS
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. PHARMA & BIOTECH COMPANIES
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. MARKET BY GEOGRAPHY
11.4. DIAGNOSTIC LABORATORIES
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. MARKET BY GEOGRAPHY
11.5. RESEARCH INSTITUTES & LABS
11.5.1. MARKET OVERVIEW
11.5.2. MARKET SIZE & FORECAST
11.5.3. MARKET BY GEOGRAPHY
11.6. CDMOS & CROS
11.6.1. MARKET OVERVIEW
11.6.2. MARKET SIZE & FORECAST
11.6.3. MARKET BY GEOGRAPHY
11.7. OTHER END-USERS
11.7.1. MARKET OVERVIEW
11.7.2. MARKET SIZE & FORECAST
11.7.3. MARKET BY GEOGRAPHY
12 GEOGRAPHY
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. GEOGRAPHIC OVERVIEW
13 NORTH AMERICA
13.1. MARKET OVERVIEW
13.2. MARKET SIZE & FORECAST
13.3. PRODUCT
13.3.1. MARKET SIZE & FORECAST
13.4. APPLICATION
13.4.1. MARKET SIZE & FORECAST
13.5. END-USERS
13.5.1. MARKET SIZE & FORECAST
13.6. KEY COUNTRIES
13.6.1. US: MARKET SIZE & FORECAST
13.6.2. CANADA: MARKET SIZE & FORECAST
14 EUROPE
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.3. PRODUCT
14.3.1. MARKET SIZE & FORECAST
14.4. APPLICATION
14.4.1. MARKET SIZE & FORECAST
14.5. END-USERS
14.5.1. MARKET SIZE & FORECAST
14.6. KEY COUNTRIES
14.6.1. GERMANY: MARKET SIZE & FORECAST
14.6.2. FRANCE: MARKET SIZE & FORECAST
14.6.3. UK: MARKET SIZE & FORECAST
14.6.4. ITALY: MARKET SIZE & FORECAST
14.6.5. SPAIN: MARKET SIZE & FORECAST
14.6.6. RUSSIA: MARKET SIZE & FORECAST
14.6.7. POLAND: MARKET SIZE & FORECAST
15 APAC
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.3. PRODUCT
15.3.1. MARKET SIZE & FORECAST
15.4. APPLICATION
15.4.1. MARKET SIZE & FORECAST
15.5. END-USERS
15.5.1. MARKET SIZE & FORECAST
15.6. KEY COUNTRIES
15.6.1. CHINA: MARKET SIZE & FORECAST
15.6.2. JAPAN: MARKET SIZE & FORECAST
15.6.3. INDIA: MARKET SIZE & FORECAST
15.6.4. SOUTH KOREA: MARKET SIZE & FORECAST
15.6.5. AUSTRALIA: MARKET SIZE & FORECAST
15.6.6. INDONESIA: MARKET SIZE & FORECAST
16 LATIN AMERICA
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.3. PRODUCT
16.3.1. MARKET SIZE & FORECAST
16.4. APPLICATION
16.4.1. MARKET SIZE & FORECAST
16.5. END-USERS
16.5.1. MARKET SIZE & FORECAST
16.6. KEY COUNTRIES
16.6.1. BRAZIL: MARKET SIZE & FORECAST
16.6.2. MEXICO: MARKET SIZE & FORECAST
16.6.3. ARGENTINA: MARKET SIZE & FORECAST
17 MIDDLE EAST & AFRICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.3. PRODUCT
17.3.1. MARKET SIZE & FORECAST
17.4. APPLICATION
17.4.1. MARKET SIZE & FORECAST
17.5. END-USERS
17.5.1. MARKET SIZE & FORECAST
17.6. KEY COUNTRIES
17.6.1. TURKEY: MARKET SIZE & FORECAST
17.6.2. SAUDI ARABIA: MARKET SIZE & FORECAST
17.6.3. SOUTH AFRICA: MARKET SIZE & FORECAST
17.6.4. UAE: MARKET SIZE & FORECAST
18 COMPETITIVE LANDSCAPE
18.1. COMPETITION OVERVIEW
18.2. MARKET SHARE ANALYSIS
18.2.1. ABBOTT
18.2.2. BIO-RAD LABORATORIES
18.2.3. BOULE
18.2.4. DANAHER
18.2.5. DIATRON
18.2.6. HORIBA
18.2.7. MERCK KGAA
18.2.8. PERKINELMER
18.2.9. SIEMENS HEALTHINEERS
18.2.10. SYSMEX CORPORATION
18.2.11. THERMO FISHER SCIENTIFIC
19 KEY COMPANY PROFILES
19.1. ABBOTT
19.1.1. BUSINESS OVERVIEW
19.1.2. PRODUCT OFFERINGS
19.1.3. KEY STRATEGIES
19.1.4. KEY STRENGTHS
19.1.5. KEY OPPORTUNITIES
19.2. BIO-RAD LABORATORIES
19.2.1. BUSINESS OVERVIEW
19.2.2. PRODUCT OFFERINGS
19.2.3. KEY STRATEGIES
19.2.4. KEY STRENGTHS
19.2.5. KEY OPPORTUNITIES
19.3. BOULE
19.3.1. BUSINESS OVERVIEW
19.3.2. PRODUCT OFFERINGS
19.3.3. KEY STRATEGIES
19.3.4. KEY STRENGTHS
19.3.5. KEY OPPORTUNITIES
19.4. DANAHER
19.4.1. BUSINESS OVERVIEW
19.4.2. PRODUCT OFFERINGS
19.4.3. KEY STRATEGIES
19.4.4. KEY STRENGTHS
19.4.5. KEY OPPORTUNITIES
19.5. DIATRON
19.5.1. BUSINESS OVERVIEW
19.5.2. PRODUCT OFFERINGS
19.5.3. KEY STRATEGIES
19.5.4. KEY STRENGTHS
19.5.5. KEY OPPORTUNITIES
19.6. HORIBA
19.6.1. BUSINESS OVERVIEW
19.6.2. PRODUCT OFFERINGS
19.6.3. KEY STRATEGIES
19.6.4. KEY STRENGTHS
19.6.5. KEY OPPORTUNITIES
19.7. MERCK KGAA
19.7.1. BUSINESS OVERVIEW
19.7.2. PRODUCT OFFERINGS
19.7.3. KEY STRATEGIES
19.7.4. KEY STRENGTHS
19.7.5. KEY OPPORTUNITIES
19.8. PERKINELMER
19.8.1. BUSINESS OVERVIEW
19.8.2. PRODUCT OFFERINGS
19.8.3. KEY STRATEGIES
19.8.4. KEY STRENGTHS
19.8.5. KEY OPPORTUNITIES
19.9. SIEMENS HEALTHINEERS
19.9.1. BUSINESS OVERVIEW
19.9.2. PRODUCT OFFERINGS
19.9.3. KEY STRATEGIES
19.9.4. KEY STRENGTHS
19.9.5. KEY OPPORTUNITIES
19.10. SYSMEX CORPORATION
19.10.1. BUSINESS OVERVIEW
19.10.2. PRODUCT OFFERINGS
19.10.3. KEY STRATEGIES
19.10.4. KEY STRENGTHS
19.10.5. KEY OPPORTUNITIES
19.11. THERMO FISHER SCIENTIFIC
19.11.1. BUSINESS OVERVIEW
19.11.2. PRODUCT OFFERINGS
19.11.3. KEY STRATEGIES
19.11.4. KEY STRENGTHS
19.11.5. KEY OPPORTUNITIES
20 OTHER PROMINENT VENDORS
20.1. ADVANCED INSTRUMENTS
20.1.1. BUSINESS OVERVIEW
20.1.2. PRODUCT OFFERINGS
20.2. AGILENT TECHNOLOGIES
20.2.1. BUSINESS OVERVIEW
20.2.2. PRODUCT OFFERINGS
20.3. AXION BIOSYSTEMS
20.3.1. BUSINESS OVERVIEW
20.3.2. PRODUCT OFFERINGS
20.4. ALIGNED GENETICS (LOGOS BIOSYSTEMS)
20.4.1. BUSINESS OVERVIEW
20.4.2. PRODUCT OFFERINGS
20.5. ALPHATEC SCIENTIFIC
20.5.1. BUSINESS OVERVIEW
20.5.2. PRODUCT OFFERINGS
20.6. AGAPPE DIAGNOSTICS
20.6.1. BUSINESS OVERVIEW
20.6.2. PRODUCT OFFERINGS
20.7. ANALYTICON BIOTECHNOLOGIES
20.7.1. BUSINESS OVERVIEW
20.7.2. PRODUCT OFFERINGS
20.8. BALIO DIAGNOSTICS
20.8.1. BUSINESS OVERVIEW
20.8.2. PRODUCT OFFERINGS
20.9. B&E BIO-TECHNOLOGY
20.9.1. BUSINESS OVERVIEW
20.9.2. PRODUCT OFFERINGS
20.10. BIOSYSTEMS DIAGNOSTICS
20.10.1. BUSINESS OVERVIEW
20.10.2. PRODUCT OFFERINGS
20.11. BIOWAY BIOLOGICAL TECHNOLOGY
20.11.1. BUSINESS OVERVIEW
20.11.2. PRODUCT OFFERINGS
20.12. BIOSYS SCIENTIFIC DEVICES GMBH
20.12.1. BUSINESS OVERVIEW
20.12.2. PRODUCT OFFERINGS
20.13. BENCHMARK SCIENTIFIC
20.13.1. BUSINESS OVERVIEW
20.13.2. PRODUCT OFFERINGS
20.14. BD
20.14.1. BUSINESS OVERVIEW
20.14.2. PRODUCT OFFERINGS
20.15. BRUKER SPATIAL BIOLOGY (NANOSTRING TECHNOLOGIES, INC.)
20.15.1. BUSINESS OVERVIEW
20.15.2. PRODUCT OFFERINGS
20.16. BENTLEY INSTRUMENTS
20.16.1. BUSINESS OVERVIEW
20.16.2. PRODUCT OFFERINGS
20.17. CHEMOMETEC
20.17.1. BUSINESS OVERVIEW
20.17.2. PRODUCT OFFERINGS
20.18. CORNING INCORPORATED
20.18.1. BUSINESS OVERVIEW
20.18.2. PRODUCT OFFERINGS
20.19. CURIOSIS INC
20.19.1. BUSINESS OVERVIEW
20.19.2. PRODUCT OFFERINGS
20.20. CYTEK BIOSCIENCES
20.20.1. BUSINESS OVERVIEW
20.20.2. PRODUCT OFFERINGS
20.21. COLE-PARMER INSTRUMENT COMPANY
20.21.1. BUSINESS OVERVIEW
20.21.2. PRODUCT OFFERINGS
20.22. CELLULAR TECHNOLOGY LTD (IMMUNOSPOT)
20.22.1. BUSINESS OVERVIEW
20.22.2. PRODUCT OFFERINGS
20.23. CLINDIAG SYSTEMS
20.23.1. BUSINESS OVERVIEW
20.23.2. PRODUCT OFFERINGS
20.24. CONTECH MEDICAL SYSTEMS
20.24.1. BUSINESS OVERVIEW
20.24.2. PRODUCT OFFERINGS
20.25. CONVERGENT TECHNOLOGIES
20.25.1. BUSINESS OVERVIEW
20.25.2. PRODUCT OFFERINGS
20.26. CPC DIAGNOSTICS
20.26.1. BUSINESS OVERVIEW
20.26.2. PRODUCT OFFERINGS
20.27. DIAGON
20.27.1. BUSINESS OVERVIEW
20.27.2. PRODUCT OFFERINGS
20.28. DIRUI
20.28.1. BUSINESS OVERVIEW
20.28.2. PRODUCT OFFERINGS
20.29. DRUCKER DIAGNOSTICS
20.29.1. BUSINESS OVERVIEW
20.29.2. PRODUCT OFFERINGS
20.30. DENOVIX
20.30.1. BUSINESS OVERVIEW
20.30.2. PRODUCT OFFERINGS
20.31. EDAN INSTRUMENTS
20.31.1. BUSINESS OVERVIEW
20.31.2. PRODUCT OFFERINGS
20.32. F. HOFFMAN-LA ROCHE
20.32.1. BUSINESS OVERVIEW
20.32.2. PRODUCT OFFERINGS
20.33. GENRUI BIOTECH
20.33.1. BUSINESS OVERVIEW
20.33.2. PRODUCT OFFERINGS
20.34. HIGH TECHNOLOGY
20.34.1. BUSINESS OVERVIEW
20.34.2. PRODUCT OFFERINGS
20.35. HOSPITEX INTERNATIONAL LTD
20.35.1. BUSINESS OVERVIEW
20.35.2. PRODUCT OFFERINGS
20.36. LINEAR CHEMICALS
20.36.1. BUSINESS OVERVIEW
20.36.2. PRODUCT OFFERINGS
20.37. MACCURA BIOTECHNOLOGY
20.37.1. BUSINESS OVERVIEW
20.37.2. PRODUCT OFFERINGS
20.38. MERIL LIFE SCIENCES
20.38.1. BUSINESS OVERVIEW
20.38.2. PRODUCT OFFERINGS
20.39. MEDSOURCE OZONE BIOMEDICALS
20.39.1. BUSINESS OVERVIEW
20.39.2. PRODUCT OFFERINGS
20.40. NIHON KODEN CORPORATION
20.40.1. BUSINESS OVERVIEW
20.40.2. PRODUCT OFFERINGS
20.41. NORMA INSTRUMENTS
20.41.1. BUSINESS OVERVIEW
20.41.2. PRODUCT OFFERINGS
20.42. NANOENTEK
20.42.1. BUSINESS OVERVIEW
20.42.2. PRODUCT OFFERINGS
20.43. PAUL MARIENFELD GMBH & CO. KG.
20.43.1. BUSINESS OVERVIEW
20.43.2. PRODUCT OFFERINGS
20.44. RWD LIFE SCIENCES CO LTD.
20.44.1. BUSINESS OVERVIEW
20.44.2. PRODUCT OFFERINGS
20.45. REVVITY
20.45.1. BUSINESS OVERVIEW
20.45.2. PRODUCT OFFERINGS
20.46. SARTORIUS AG
20.46.1. BUSINESS OVERVIEW
20.46.2. PRODUCT OFFERINGS
20.47. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
20.47.1. BUSINESS OVERVIEW
20.47.2. PRODUCT OFFERINGS
20.48. SHENZHEN LANDWIND INDUSTRY
20.48.1. BUSINESS OVERVIEW
20.48.2. PRODUCT OFFERINGS
20.49. PRESTIGE DIAGNOSTICS
20.49.1. BUSINESS OVERVIEW
20.49.2. PRODUCT OFFERINGS
20.50. SFRI
20.50.1. BUSINESS OVERVIEW
20.50.2. PRODUCT OFFERINGS
20.51. SHENZHEN DYMIND BIOTECHNOLOGY
20.51.1. BUSINESS OVERVIEW
20.51.2. PRODUCT OFFERINGS
20.52. SHENZHEN PROKAN ELECTRONICS
20.52.1. BUSINESS OVERVIEW
20.52.2. PRODUCT OFFERINGS
20.53. SPINREACT
20.53.1. BUSINESS OVERVIEW
20.53.2. PRODUCT OFFERINGS
20.54. TRIVITRON HEALTHCARE.
20.54.1. BUSINESS OVERVIEW
20.54.2. PRODUCT OFFERINGS
20.55. TECAN TRADING AG
20.55.1. BUSINESS OVERVIEW
20.55.2. PRODUCT OFFERINGS
20.56. TIP BIOSYSTEMS
20.56.1. BUSINESS OVERVIEW
20.56.2. PRODUCT OFFERINGS
21 REPORT SUMMARY
21.1. KEY TAKEAWAYS
21.2. STRATEGIC RECOMMENDATIONS
22 QUANTITATIVE SUMMARY
22.1. MARKET BY GEOGRAPHY
22.2. MARKET BY-PRODUCTS
22.3. MARKET BY APPLICATION
22.4. MARKET BY END-USERS
23 APPENDIX
23.1. RESEARCH METHODOLOGY
23.2. RESEARCH PROCESS
23.3. REPORT ASSUMPTIONS & CAVEATS
23.3.1. KEY CAVEATS
23.3.2. CURRENCY CONVERSION
23.4. ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the growth rate of the global cell counting devices market?
How big is the cell counting devices market?
What are the significant trends in the cell counting devices industry?
Which region dominates the global cell counting devices market share?
Who are the key players in the global cell counting devices market?